Metraipolis › archive › dc_a33c4104fbfe

Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer — Europe PMC PMID:38033156

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38033156
DOI
10.1371/journal.pgen.1011043
License (as archived)
CC0-1.0
Archived
2026-10-07T11:30:57.848Z
SHA-256 of the archived text
aa2753326fe33cf1001d812a04aedab5aedc84d704d0963fe5ffc3d40cf8e96a
Stable URL of this page
https://metraipolis.com/documento/dc_a33c4104fbfe

How to cite

Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer — Europe PMC PMID:38033156 — Europe PMC (en), https://europepmc.org/article/MED/38033156 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_a33c4104fbfe (Metraipolis archive dc_a33c4104fbfe, sha256 aa2753326fe33cf1001d812a04aedab5aedc84d704d0963fe5ffc3d40cf8e96a)
BibTeX
@misc{dca33c4104fbfe,
  title = {Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer — Europe PMC PMID:38033156},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38033156},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_a33c4104fbfe; sha256 aa2753326fe33cf1001d812a04aedab5aedc84d704d0963fe5ffc3d40cf8e96a},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38033156. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

A prominent source of mutation in cancer is single-stranded DNA cytosine deamination by cellular APOBEC3 enzymes, which results in signature C-to-T and C-to-G mutations in TCA and TCT motifs. Although multiple enzymes have been implicated, reports conflict and it is unclear which protein(s) are responsible. Here we report the development of a selectable system to quantify genome mutation and demonstrate its utility by comparing the mutagenic activities of three leading candidates-APOBEC3A, APOBEC3B, and APOBEC3H. The human cell line, HAP1, is engineered to express the thymidine kinase (TK) gene of HSV-1, which confers sensitivity to ganciclovir. Expression of APOBEC3A and APOBEC3B, but not catalytic mutant controls or APOBEC3H, triggers increased frequencies of TK mutation and similar TC-biased cytosine mutation profiles in the selectable TK reporter gene. Whole genome sequences from independent clones enabled an analysis of thousands of single base substitution mutations and extraction of local sequence preferences with APOBEC3A preferring YTCW motifs 70% of the time and APOBEC3B 50% of the time (Y = C/T; W = A/T). Signature comparisons with breast tumor whole genome sequences indicate that most malignancies manifest intermediate percentages of APOBEC3 signature mutations in YTCW motifs, mostly between 50 and 70%, suggesting that both enzymes contribute in a combinatorial manner to the overall mutation landscape. Although the vast majority of APOBEC3A- and APOBEC3B-induced single base substitution mutations occur outside of predicted chromosomal DNA hairpin structures, whole genome sequence analyses and supporting biochemical studies also indicate that both enzymes are capable of deaminating the single-stranded loop regions of DNA hairpins at elevated rates. These studies combine to help resolve a long-standing etiologic debate on the source of APOBEC3 signature mutations in cancer and indicate that future diagnostic and therapeutic efforts should focus on both APOBEC3A and APOBEC3B.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS genetics, 2023 (prima pubblicazione 2023-11-30).
Identificativi: PMID 38033156 · PMCID PMC10715669 · DOI 10.1371/journal.pgen.1011043.
Descrittori MeSH principali: Breast Neoplasms.
Pagina: https://europepmc.org/article/MED/38033156 — https://doi.org/10.1371/journal.pgen.1011043. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T11:17:31.064Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.